Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2377641
Max Phase: Preclinical
Molecular Formula: C14H12Br2N2O
Molecular Weight: 384.07
Molecule Type: Small molecule
Associated Items:
ID: ALA2377641
Max Phase: Preclinical
Molecular Formula: C14H12Br2N2O
Molecular Weight: 384.07
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cn1c(/C=C/C(=O)c2cccc(N)c2)cc(Br)c1Br
Standard InChI: InChI=1S/C14H12Br2N2O/c1-18-11(8-12(15)14(18)16)5-6-13(19)9-3-2-4-10(17)7-9/h2-8H,17H2,1H3/b6-5+
Standard InChI Key: PSZGGOCMKVZKTB-AATRIKPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.07 | Molecular Weight (Monoisotopic): 381.9316 | AlogP: 4.03 | #Rotatable Bonds: 3 |
Polar Surface Area: 48.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.00 | CX LogP: 3.52 | CX LogD: 3.52 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.49 | Np Likeness Score: -0.26 |
1. Rane RA, Sahu NU, Gutte SD, Mahajan AA, Shah CP, Bangalore P.. (2013) Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents., 63 [PMID:23584542] [10.1016/j.ejmech.2013.03.029] |
Source(1):